image
Merit Medical Systems, Inc. MMSI
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
Watchlist
$ 91.98
-1.04 %
$ 5.44 B
Market Cap
45.09
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one MMSI stock under the worst case scenario is HIDDEN Compared to the current market price of 92 USD, Merit Medical Systems, Inc. is HIDDEN

MMSI Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one MMSI stock under the base case scenario is HIDDEN Compared to the current market price of 92 USD, Merit Medical Systems, Inc. is HIDDEN

MMSI Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one MMSI stock under the best case scenario is HIDDEN Compared to the current market price of 92 USD, Merit Medical Systems, Inc. is HIDDEN

MMSI Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart MMSI

image
1M -5%
6M -6%
1Y 10%
3Y 71%
5Y 119%
All
$115.0$115.0$110.0$110.0$105.0$105.0$100.0$100.0$95.0$95.0$90.0$90.0$85.0$85.0Jan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 Jun
FINANCIALS
1.36 B REVENUE
7.89%
Growth Rates
1Year 7.89%
3Years 8.07%
5Years 6.40%
7Years 9.30%
10Years 10.28%
156 M OPERATING INCOME
25.62%
Growth Rates
1Year 25.62%
3Years 36.72%
5Years 34.30%
7Years 24.77%
10Years 14.51%
120 M NET INCOME
27.48%
Growth Rates
1Year 27.48%
3Years 35.43%
5Years 85.69%
7Years 23.46%
10Years 18.01%
221 M OPERATING CASH FLOW
52.12%
Growth Rates
1Year 52.12%
3Years 14.46%
5Years 23.19%
7Years 19.70%
10Years 15.27%
-369 M INVESTING CASH FLOW
-110.24%
Growth Rates
1Year -110.24%
3Years -114.87%
5Years -22.35%
7Years -14.06%
10Years -26.12%
-60 M FINANCING CASH FLOW
-10.73%
Growth Rates
1Year -10.73%
3Years 15.21%
5Years -22.77%
7Years -7.15%
10Years -13.46%
355 M REVENUE
0.05%
Growth Rates
1Year 7.89%
3Years 8.07%
5Years 6.40%
7Years 9.30%
10Years 10.28%
41 M OPERATING INCOME
12.22%
Growth Rates
1Year 25.62%
3Years 36.72%
5Years 34.30%
7Years 24.77%
10Years 14.51%
30.1 M NET INCOME
7.87%
Growth Rates
1Year 27.48%
3Years 35.43%
5Years 85.69%
7Years 23.46%
10Years 18.01%
40.6 M OPERATING CASH FLOW
-40.98%
Growth Rates
1Year 52.12%
3Years 14.46%
5Years 23.19%
7Years 19.70%
10Years 15.27%
-29.6 M INVESTING CASH FLOW
86.18%
Growth Rates
1Year -110.24%
3Years -114.87%
5Years -22.35%
7Years -14.06%
10Years -26.12%
6.96 M FINANCING CASH FLOW
185.98%
Growth Rates
1Year -10.73%
3Years 15.21%
5Years -22.77%
7Years -7.15%
10Years -13.46%
Balance Sheet Merit Medical Systems, Inc.
image
Current Assets 924 M
Cash & Short-Term Investments 379 M
Receivables 209 M
Other Current Assets 336 M
Non-Current Assets 1.49 B
Long-Term Investments 22.8 M
PP&E 452 M
Other Non-Current Assets 1.02 B
15.66 %8.65 %13.88 %18.67 %42.19 %Total Assets$2.4b
Current Liabilities 216 M
Accounts Payable 68.5 M
Short-Term Debt 10.3 M
Other Current Liabilities 138 M
Non-Current Liabilities 823 M
Long-Term Debt 784 M
Other Non-Current Liabilities 38.5 M
6.59 %13.24 %75.47 %3.71 %Total Liabilities$1.0b
EFFICIENCY
Earnings Waterfall Merit Medical Systems, Inc.
image
Revenue 1.36 B
Cost Of Revenue 713 M
Gross Profit 643 M
Operating Expenses 461 M
Operating Income 156 M
Other Expenses 35.3 M
Net Income 120 M
1b1b1b1b1b1b800m800m600m600m400m400m200m200m001b(713m)643m(461m)156m(35m)120mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
47.43% GROSS MARGIN
47.43%
Averages
1Year 47.43%
3Years 46.32%
5Years 45.15%
7Years 44.85%
10Years 44.61%
11.48% OPERATING MARGIN
11.48%
Averages
1Year 11.48%
3Years 9.65%
5Years 5.62%
7Years 4.02%
10Years 4.54%
8.87% NET MARGIN
8.87%
Averages
1Year 8.87%
3Years 7.62%
5Years 5.27%
7Years 4.52%
10Years 4.32%
8.73% ROE
8.73%
Averages
1Year 8.73%
3Years 7.70%
5Years 5.34%
7Years 4.54%
10Years 4.50%
4.98% ROA
4.98%
Averages
1Year 4.98%
3Years 4.50%
5Years 3.17%
7Years 2.68%
10Years 2.64%
5.65% ROIC
5.65%
Averages
1Year 5.65%
3Years 5.30%
5Years 3.32%
7Years 1.40%
10Years 1.96%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Merit Medical Systems, Inc.
image
200m200m180m180m160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m00(20m)(20m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 120 M
Depreciation & Amortization 115 M
Capital Expenditures -38 M
Stock-Based Compensation 28.5 M
Change in Working Capital -36.9 M
Others -11.9 M
Free Cash Flow 183 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Merit Medical Systems, Inc.
image
Wall Street analysts predict an average 1-year price target for MMSI of $106 , with forecasts ranging from a low of $92 to a high of $125 .
MMSI Lowest Price Target Wall Street Target
92 USD 0.02%
MMSI Average Price Target Wall Street Target
106 USD 15.60%
MMSI Highest Price Target Wall Street Target
125 USD 35.90%
Price
Max Price Target
Min Price Target
Average Price Target
1251251201201151151101101051051001009595909085858080Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 11
6. Ownership
Insider Ownership Merit Medical Systems, Inc.
image
Sold
0-3 MONTHS
8.53 M USD 7
3-6 MONTHS
13.4 M USD 6
6-9 MONTHS
5.21 M USD 3
9-12 MONTHS
1.06 M USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
XRAY vs. MMSI: Which Stock Is the Better Value Option? Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 1 week ago
ALGN vs. MMSI: Which Stock Should Value Investors Buy Now? Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Merit Medical (MMSI). But which of these two stocks is more attractive to value investors? zacks.com - 1 month ago
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio Merit Medical aims to provide an additional effective solution that complements a wide range of percutaneous procedures, including interventional radiology and cardiology. zacks.com - 1 month ago
Merit Medical Acquires Biolife Delaware, L.L.C. SOUTH JORDAN, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that it has acquired Biolife Delaware, L.L.C. (“Biolife”) in a merger transaction through which Biolife has become a wholly-owned subsidiary of Merit. Biolife, which is headquartered in Sarasota, Florida, manufactures unique patented hemostatic devices under the brand names StatSeal and WoundSeal. globenewswire.com - 1 month ago
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis SOUTH JORDAN, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the Wrapsody Cell-Impermeable Endoprosthesis (CIE) received regulatory approval from Health Canada. With this approval, Merit intends to begin immediate commercialization of the device throughout Canada with devices shipped from Merit's Toronto distribution center. globenewswire.com - 1 month ago
LH vs. MMSI: Which Stock Is the Better Value Option? Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Labcorp (LH) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 1 month ago
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months. In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months. globenewswire.com - 1 month ago
MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up Merit Medical benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter of 2025. zacks.com - 2 months ago
Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q1 2025 Results Conference Call April 24, 2025 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Raul Parra - Chief Financial Officer and Treasurer Brian Lloyd - Chief Legal Officer & Corporate Secretary Conference Call Participants Jason Bednar - Piper Sandler Steve Lichtman - Oppenheimer Robbie Marcus - J.P. Morgan Craig Bijou - Bank of America Securities David Rescott - Baird Michael Petusky - Barrington Research Jim Sidoti - Sidoti & Company Jon Young - Canaccord Mike Matson - Needham Jayson Bedford - Raymond James Operator Welcome to the Merit Medical Systems First Quarter 2025 Earnings Conference Call. seekingalpha.com - 2 months ago
Compared to Estimates, Merit Medical (MMSI) Q1 Earnings: A Look at Key Metrics Although the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 months ago
Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates Merit Medical (MMSI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.77 per share a year ago. zacks.com - 2 months ago
What Analyst Projections for Key Metrics Reveal About Merit Medical (MMSI) Q1 Earnings Beyond analysts' top -and-bottom-line estimates for Merit Medical (MMSI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025. zacks.com - 2 months ago
8. Profile Summary

Merit Medical Systems, Inc. MMSI

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 5.44 B
Dividend Yield 0.00%
Description Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
Contact 1600 West Merit Parkway, South Jordan, UT, 84095 https://www.merit.com
IPO Date May 14, 1990
Employees 7400
Officers Mr. Brian G. Lloyd J.D. Chief Legal Officer & Corporate Secretary Mr. John Knorpp Chief Regulatory Affairs Officer Mr. Fred P. Lampropoulos Founder, Chief Executive Officer, President & Chairman Ms. Sarah Comstock Vice President of Global Communications Mr. Raul Parra Jr., CPA Chief Financial Officer & Treasurer Mr. Neil W. Peterson Chief Operating Officer Mr. Jason Treft Chief Information Officer Mr. Michel J. Voigt Chief Human Resources Officer Mr. Ricardo Alvarez Managing Director of Operation Merit Medical Tijuana Mr. Mark Butler Executive Vice President of Merit Medical EMEA